Director, Commercial, Netherlands

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.

As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Commercial Lead in the Netherlands is responsible for defining and executing the local commercial strategy for RevMEd portfolio and launches. This role is accountable for building the commercial organization, driving launch and growth performance, and ensuring strong alignment across Medical Affairs, Market Access, and other key functions.

Benefits

The Commercial Lead in the Netherlands will oversee the generation of insights from the therapeutic field and translate these insights into a comprehensive, cross-functional commercial strategy. In support of clear positioning and an aligned communication approach, the incumbent will also ensure the development and implementation of tactics and tools that enable the field force to effectively address customer needs.

Responsibilities

: Act as the commercial lead for Netherlands, accountable for local commercial strategy, execution, and performance across the oncology portfolio. Serve as a core member of the Netherlands Leadership Team, contributing to country strategy, launch planning, and key business decisions. Partner with regional and local Medical Affairs and Market Access teams to translate clinical and economic evidence into compelling value communications tailored to Netherlands stakeholders, including HCPs and payers.

Requirements

, in close collaboration with the European commercial team. Represent Netherlands in regional commercial discussions and contribute country insights to shape broader commercial plans and strategy. Develop and execute country-level brand and portfolio strategies across pre-launch, launch, and post-launch phases.

Drive demand generation and appropriate use through non-promotional and promotional channels, in compliance with local regulations. Lead forecasting, budgeting, and operational planning for the country in close collaboration with the ED, Commercial Excellence, Business Analytics and Insights, Europe. Lead commercial launch readiness for oncology products, including customer strategy, segmentation, targeting, and field force planning.

Partner closely with Medical Affairs and Market Access to ensure integrated launch execution and consistent external engagement. Monitor performance, competitive dynamics, and market trends, adjusting strategy and execution as needed. Oversee engagement strategy across key stakeholders, including oncologists, treatment centers, and healthcare organizations.

Ensure effective field force deployment and capability building. Build, lead, and develop the country commercial organization, including sales, marketing, and customer-facing roles as the business scales.